Guidant's woes deepen with Spitzer on warpath over ICD (implantable cardioverter defibrillator) fault
This article was originally published in Clinica
Not only does Guidant have to face the possibility of its buyer walking out on the biggest merger deal in medtech history, the company now has to contend with a lawsuit filed by New York Attorney General Eliot Spitzer.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.